Find and Pitch Jounalists, Get Your Story Covered

Tags: Camber Pharmaceuticals Generic Bentyl Gastrointestinal disorders Gabapentin Oral Solution Generic Neurontin

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Pharmacist's Role in Duloxetine Therapy: Improving Medication Adherence in Older Adults With Depression, Pain - 20 days ago FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - 11 months ago
2	The Conversation Science Alert Science news. Official account. Australia science news	New Non-Opioid Painkiller First in Decades to Win FDA Approval - 26 days ago Deaths Linked to a Common Anxiety Drug Have Surged in The UK - 12 months ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects - 26 days ago Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds - about 1 month ago Startup SiteOne Secures $100M to Forge Ahead With Novel Non-Opioid Pain Meds - 3 months ago Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition - 5 months ago Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test - 7 months ago FDA Approves Argenx Drug as First New Treatment in Decades for Rare Nerve Disease CIDP - 8 months ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Angelini Ventures co-leads Series A financing in Neumirna Therapeutics - about 2 months ago NICE endorses Neuraxpharm’s ublituximab for treating MS - 3 months ago
5	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Gabapentin May Not Raise the Risk of Falling After All - about 2 months ago Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis - 5 months ago Novel Agent Reduces Monthly Migraine Days - 6 months ago Gabapentin for Everything; New Brunswick Brain Mystery; Replacing Bits of Old Brain - 7 months ago ALS Therapy to Be Pulled From the Market, Drugmaker Says - 11 months ago Alzheimer's Supplements Fail Compared With Generic Drugs - about 1 year ago FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugs - over 1 year ago Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variant - over 1 year ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Neumora’s antidepressant stumbles in first Phase 3 trial readout - 2 months ago STAT+: Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results - 2 months ago
7	Kristen Monaco MedPage Today	Cymbalta Bottles Recalled; 1 in 3 Older Adults Are Lonely; Walking Off Depression - 3 months ago Clonazepam Recall Expands; Lipid Depression Screening; Period Pain and Depression - 3 months ago
8	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Spravato is just the beginning in a new wave of depression meds - 4 months ago After Vyvanse patent loss, Takeda’s neuroscience division looks to enter a new era - 10 months ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pegfilgrastim-Fpgk Shows Structural, Functional Biosimilarity to Reference Product - 4 months ago FDA Accepts Resubmitted NDA for AXS-07 for Acute Treatment of Migraine - 6 months ago FDA Accepts New Drug Application for Suzetrigine to Manage Acute Pain - 7 months ago Teva Launches Generic Formulation of Liraglutide in US - 8 months ago FDA Issues Warning Of Antiseizure Medications Causing Rare, Serious Reactions - over 1 year ago Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs - over 1 year ago
10	Jessica Rendall CNET Journalist/Presenter @abcdarwin. Brisbane JournalismBroadcasting	Thousands of Antidepressant Bottles Were Recalled Over 'Impurity' Risk: Here's More Context - 4 months ago

Journalists covering Generic Neurontin